At single-cell level, HCC cells exhibiting high SPINK1 expression demonstrate resistance to therapy through an active drug metabolic signaling pathway, a process facilitated by the histological co-expression of SPINK1 with CES2 and CYP3A5. This evidence concerns the gene CYP3A5 and hepatocellular carcinoma.